Drugs target to ENPP3

Drug name Drug type Disease/phenotype Mechanism of action(MoA) Phase Status Source
AGS-16C3FUnknownrenal cell carcinomaEctonucleotide pyrophosphatase/phosphodiesterase family member 3 binding agent2.0CompletedClinicalTrials
AGS-16C3FUnknownclear cell renal carcinomaEctonucleotide pyrophosphatase/phosphodiesterase family member 3 binding agent1.0CompletedClinicalTrials